

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.48763262 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.21920231 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.21920231 |
| 4 | cellular extravasation (GO:0045123) | 5.03368018 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.99611189 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.87774347 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84030867 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66885940 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50493453 |
| 10 | histone H3-K4 trimethylation (GO:0080182) | 4.37131977 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36111141 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34063793 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 4.31089838 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.21610610 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.19734285 |
| 16 | negative thymic T cell selection (GO:0045060) | 4.12734704 |
| 17 | positive regulation of granulocyte differentiation (GO:0030854) | 4.05468398 |
| 18 | negative T cell selection (GO:0043383) | 3.96861110 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.95247864 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.95247864 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.95247864 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.95247864 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.95247864 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.95247864 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.93018423 |
| 26 | mannose metabolic process (GO:0006013) | 3.84863765 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.76631541 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72931687 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62193159 |
| 30 | activated T cell proliferation (GO:0050798) | 3.57190324 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.51932584 |
| 32 | T cell selection (GO:0045058) | 3.49626015 |
| 33 | germinal center formation (GO:0002467) | 3.46738269 |
| 34 | detection of other organism (GO:0098543) | 3.46358059 |
| 35 | thymic T cell selection (GO:0045061) | 3.41593325 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.41446791 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.39946864 |
| 38 | detection of bacterium (GO:0016045) | 3.39022246 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34402835 |
| 40 | positive T cell selection (GO:0043368) | 3.30185273 |
| 41 | response to interleukin-15 (GO:0070672) | 3.29924523 |
| 42 | regulation of ARF protein signal transduction (GO:0032012) | 3.28703695 |
| 43 | response to peptidoglycan (GO:0032494) | 3.26424587 |
| 44 | leukocyte aggregation (GO:0070486) | 3.25569465 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.22690694 |
| 46 | T cell migration (GO:0072678) | 3.21601093 |
| 47 | histone H3-K9 modification (GO:0061647) | 3.21519354 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.13396773 |
| 49 | regulation of granulocyte differentiation (GO:0030852) | 3.10462614 |
| 50 | histone H3-K36 demethylation (GO:0070544) | 3.05016417 |
| 51 | response to host defenses (GO:0052200) | 3.03283108 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03283108 |
| 53 | response to host (GO:0075136) | 3.03283108 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02769960 |
| 55 | microglial cell activation (GO:0001774) | 2.94858666 |
| 56 | peptidyl-lysine trimethylation (GO:0018023) | 2.94371257 |
| 57 | detection of external biotic stimulus (GO:0098581) | 2.92839219 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 2.91676623 |
| 59 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.90242578 |
| 60 | Peyers patch development (GO:0048541) | 2.90242578 |
| 61 | natural killer cell differentiation (GO:0001779) | 2.86895470 |
| 62 | response to host immune response (GO:0052572) | 2.85076185 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85076185 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83310210 |
| 65 | dosage compensation (GO:0007549) | 2.82909662 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.79490479 |
| 67 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.79109533 |
| 68 | positive regulation of myotube differentiation (GO:0010831) | 2.78834941 |
| 69 | T cell homeostasis (GO:0043029) | 2.77589481 |
| 70 | positive regulation of Rap GTPase activity (GO:0032854) | 2.76831507 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.73848907 |
| 72 | regulation of ARF GTPase activity (GO:0032312) | 2.68237457 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 2.68003093 |
| 74 | cellular response to interleukin-15 (GO:0071350) | 2.67459259 |
| 75 | striated muscle atrophy (GO:0014891) | 2.66575904 |
| 76 | histone H3-K9 methylation (GO:0051567) | 2.66193038 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.64095745 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63956070 |
| 79 | B cell homeostasis (GO:0001782) | 2.63836092 |
| 80 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63806538 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62614292 |
| 82 | histone H3-K4 methylation (GO:0051568) | 2.61405136 |
| 83 | regulation of histone H3-K27 methylation (GO:0061085) | 2.59884681 |
| 84 | detection of biotic stimulus (GO:0009595) | 2.59439125 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 2.58900495 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.58799966 |
| 87 | positive regulation of protein deacetylation (GO:0090312) | 2.57434244 |
| 88 | negative regulation of myotube differentiation (GO:0010832) | 2.54914640 |
| 89 | negative regulation of type 2 immune response (GO:0002829) | 2.54103895 |
| 90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.53513193 |
| 91 | peptidyl-lysine methylation (GO:0018022) | 2.52204782 |
| 92 | histone lysine methylation (GO:0034968) | 2.51840696 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.50782973 |
| 94 | histone H4 deacetylation (GO:0070933) | 2.50744083 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50281029 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.50216854 |
| 97 | neutrophil mediated immunity (GO:0002446) | 2.50136701 |
| 98 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.49190445 |
| 99 | histone deubiquitination (GO:0016578) | 2.49016188 |
| 100 | lymphocyte homeostasis (GO:0002260) | 2.48068609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86388642 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.71195404 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.65887482 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.61840704 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.34199408 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99668580 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.90301323 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.82796011 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.65119563 |
| 10 | SPI1_23127762_ChIP-Seq_K562_Human | 2.57003731 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.56303496 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.53342633 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.52990647 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52950536 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51880185 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.49695796 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.49073203 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48406639 |
| 19 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.35816333 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.34852755 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.28803655 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26205292 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14905054 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05658291 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.03753759 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.03012110 |
| 27 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.01514230 |
| 28 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.97736731 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96739414 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94473135 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92840931 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92513403 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91501291 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90769931 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84678628 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83562663 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.83445826 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82520959 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79019901 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77433970 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76982516 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76460863 |
| 43 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.76245675 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73717999 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.72684812 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71308974 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69087556 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61988923 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60176489 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55803850 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55608040 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53159908 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52928849 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52830806 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51934044 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.42143922 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39621159 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38218555 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37483661 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35689842 |
| 61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31974242 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29749541 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27122008 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.23008092 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20746522 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20372028 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19920583 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18569137 |
| 69 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18539060 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17473782 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17410690 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17240367 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14998736 |
| 74 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13632352 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11842347 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11785563 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10127673 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09855785 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07278038 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07169334 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06260632 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06202665 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04186123 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03335681 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03273087 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02381455 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00471954 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98155965 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97822500 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97035187 |
| 91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96492853 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96278544 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95531188 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93805059 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93390473 |
| 96 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.92730611 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92265638 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91596312 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91478262 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90051217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.57572467 |
| 2 | MP0003436_decreased_susceptibility_to | 3.28900482 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.15669465 |
| 4 | MP0001800_abnormal_humoral_immune | 2.83576879 |
| 5 | MP0009278_abnormal_bone_marrow | 2.73914667 |
| 6 | MP0000685_abnormal_immune_system | 2.72534228 |
| 7 | MP0003303_peritoneal_inflammation | 2.69935910 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.59071264 |
| 9 | MP0003646_muscle_fatigue | 2.57064541 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.55206745 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.43897295 |
| 12 | MP0005451_abnormal_body_composition | 2.43750803 |
| 13 | MP0008260_abnormal_autophagy | 2.41388952 |
| 14 | MP0004130_abnormal_muscle_cell | 2.37935372 |
| 15 | MP0002419_abnormal_innate_immunity | 2.37572578 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.32354314 |
| 17 | MP0002723_abnormal_immune_serum | 2.30791418 |
| 18 | MP0005671_abnormal_response_to | 2.29811849 |
| 19 | MP0005025_abnormal_response_to | 2.29769434 |
| 20 | MP0001819_abnormal_immune_cell | 2.26605820 |
| 21 | MP0005387_immune_system_phenotype | 2.24281779 |
| 22 | MP0001790_abnormal_immune_system | 2.24281779 |
| 23 | MP0002398_abnormal_bone_marrow | 2.23964494 |
| 24 | MP0003724_increased_susceptibility_to | 2.19042477 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.12956341 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.08516924 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.08516924 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.98676184 |
| 29 | MP0000716_abnormal_immune_system | 1.95416115 |
| 30 | MP0004381_abnormal_hair_follicle | 1.84586820 |
| 31 | MP0002405_respiratory_system_inflammati | 1.78761455 |
| 32 | MP0002722_abnormal_immune_system | 1.69423443 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.65710278 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.65339841 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.62169996 |
| 36 | MP0004947_skin_inflammation | 1.58817713 |
| 37 | MP0002429_abnormal_blood_cell | 1.58129742 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.57942637 |
| 39 | MP0008057_abnormal_DNA_replication | 1.57632903 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.56795227 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.53762015 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.46019031 |
| 43 | MP0003690_abnormal_glial_cell | 1.45489527 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.44445454 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.43551271 |
| 46 | MP0001851_eye_inflammation | 1.37454944 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.35811481 |
| 48 | MP0002933_joint_inflammation | 1.34599340 |
| 49 | MP0001873_stomach_inflammation | 1.31731962 |
| 50 | MP0003787_abnormal_imprinting | 1.31640165 |
| 51 | MP0009785_altered_susceptibility_to | 1.30382364 |
| 52 | MP0003866_abnormal_defecation | 1.28218856 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.26331014 |
| 54 | MP0002009_preneoplasia | 1.25962256 |
| 55 | MP0009115_abnormal_fat_cell | 1.25795581 |
| 56 | MP0003045_fibrosis | 1.23183655 |
| 57 | MP0005310_abnormal_salivary_gland | 1.19650545 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.17757937 |
| 59 | MP0006082_CNS_inflammation | 1.15075054 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.12622863 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.11484141 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.10149805 |
| 63 | MP0003828_pulmonary_edema | 1.09682442 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.08658471 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.07514491 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 1.03449858 |
| 67 | MP0002132_abnormal_respiratory_system | 0.97201211 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 0.94839990 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.94460904 |
| 70 | MP0008469_abnormal_protein_level | 0.92810628 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.89745577 |
| 72 | MP0004036_abnormal_muscle_relaxation | 0.89458077 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.89296832 |
| 74 | MP0003329_amyloid_beta_deposits | 0.86737832 |
| 75 | MP0008569_lethality_at_weaning | 0.84706096 |
| 76 | MP0001661_extended_life_span | 0.84542463 |
| 77 | MP0002971_abnormal_brown_adipose | 0.78329510 |
| 78 | MP0004883_abnormal_blood_vessel | 0.77112132 |
| 79 | MP0003091_abnormal_cell_migration | 0.73636082 |
| 80 | MP0000858_altered_metastatic_potential | 0.73510470 |
| 81 | MP0004147_increased_porphyrin_level | 0.72390706 |
| 82 | MP0002249_abnormal_larynx_morphology | 0.72189031 |
| 83 | MP0008874_decreased_physiological_sensi | 0.70215225 |
| 84 | MP0005670_abnormal_white_adipose | 0.70204789 |
| 85 | MP0005621_abnormal_cell_physiology | 0.67146836 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.65729251 |
| 87 | MP0005409_darkened_coat_color | 0.65224507 |
| 88 | MP0004233_abnormal_muscle_weight | 0.64805594 |
| 89 | MP0000759_abnormal_skeletal_muscle | 0.64687192 |
| 90 | MP0001853_heart_inflammation | 0.63751498 |
| 91 | MP0005334_abnormal_fat_pad | 0.62668620 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.61980507 |
| 93 | MP0000604_amyloidosis | 0.61910655 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.60424095 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.60120017 |
| 96 | MP0001915_intracranial_hemorrhage | 0.59865206 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.59263547 |
| 98 | MP0003879_abnormal_hair_cell | 0.58974616 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.58862468 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.58130426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.46234344 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.19145865 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16812835 |
| 4 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.79787487 |
| 5 | Abnormality of the fingertips (HP:0001211) | 3.79126549 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.62957295 |
| 7 | Papilledema (HP:0001085) | 3.57645448 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.53287183 |
| 9 | Colitis (HP:0002583) | 3.50066009 |
| 10 | Gingivitis (HP:0000230) | 3.42039122 |
| 11 | Myositis (HP:0100614) | 3.01859442 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.00561020 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.00495410 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 2.97241101 |
| 15 | Cellulitis (HP:0100658) | 2.95954234 |
| 16 | Spontaneous hematomas (HP:0007420) | 2.93187718 |
| 17 | Meningitis (HP:0001287) | 2.92794905 |
| 18 | Inflammation of the large intestine (HP:0002037) | 2.91765060 |
| 19 | Increased IgE level (HP:0003212) | 2.84766284 |
| 20 | Prolonged bleeding time (HP:0003010) | 2.81227084 |
| 21 | Deep palmar crease (HP:0006191) | 2.80975293 |
| 22 | Obstructive lung disease (HP:0006536) | 2.78979035 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78979035 |
| 24 | Granulocytopenia (HP:0001913) | 2.71324664 |
| 25 | Agammaglobulinemia (HP:0004432) | 2.67695573 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.66258180 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.63691034 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56076688 |
| 29 | Slow saccadic eye movements (HP:0000514) | 2.52252840 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48313195 |
| 31 | Recurrent viral infections (HP:0004429) | 2.48127510 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45428674 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45428674 |
| 34 | Hypochromic anemia (HP:0001931) | 2.45004341 |
| 35 | Exercise-induced myalgia (HP:0003738) | 2.44729446 |
| 36 | Vasculitis (HP:0002633) | 2.44319956 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.43643255 |
| 38 | Leukocytosis (HP:0001974) | 2.40944747 |
| 39 | T lymphocytopenia (HP:0005403) | 2.39516857 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.36585975 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.32019442 |
| 42 | Optic neuritis (HP:0100653) | 2.32019442 |
| 43 | Orchitis (HP:0100796) | 2.31637337 |
| 44 | Macroorchidism (HP:0000053) | 2.31287666 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.30046659 |
| 46 | Chest pain (HP:0100749) | 2.29233730 |
| 47 | Ankle clonus (HP:0011448) | 2.26847991 |
| 48 | Recurrent skin infections (HP:0001581) | 2.24625045 |
| 49 | Obstructive sleep apnea (HP:0002870) | 2.24089271 |
| 50 | Metaphyseal cupping (HP:0003021) | 2.23807793 |
| 51 | Acute lymphatic leukemia (HP:0006721) | 2.22638454 |
| 52 | Encephalitis (HP:0002383) | 2.21804906 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.16715974 |
| 54 | Genetic anticipation (HP:0003743) | 2.16101801 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14185355 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.12562973 |
| 57 | Heterotopia (HP:0002282) | 2.08717600 |
| 58 | Epistaxis (HP:0000421) | 2.08657162 |
| 59 | Dysmetric saccades (HP:0000641) | 2.04416240 |
| 60 | Viral hepatitis (HP:0006562) | 1.98591285 |
| 61 | Abnormality of T cells (HP:0002843) | 1.95617521 |
| 62 | Lymphopenia (HP:0001888) | 1.95597590 |
| 63 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95305840 |
| 64 | Pustule (HP:0200039) | 1.94559301 |
| 65 | Pulmonary infiltrates (HP:0002113) | 1.93677322 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 1.92868153 |
| 67 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92390223 |
| 68 | Subaortic stenosis (HP:0001682) | 1.92390223 |
| 69 | Microcytic anemia (HP:0001935) | 1.89376760 |
| 70 | Periodontitis (HP:0000704) | 1.88765557 |
| 71 | Eosinophilia (HP:0001880) | 1.88571756 |
| 72 | Recurrent bronchitis (HP:0002837) | 1.88110683 |
| 73 | Pulmonary embolism (HP:0002204) | 1.84533139 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84426607 |
| 75 | Difficulty running (HP:0009046) | 1.84182151 |
| 76 | Diplopia (HP:0000651) | 1.83618073 |
| 77 | Abnormality of binocular vision (HP:0011514) | 1.83618073 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 1.82592019 |
| 79 | Postural instability (HP:0002172) | 1.82336357 |
| 80 | Bowel incontinence (HP:0002607) | 1.81570334 |
| 81 | Emphysema (HP:0002097) | 1.79457926 |
| 82 | Stomatitis (HP:0010280) | 1.79450632 |
| 83 | Acute myeloid leukemia (HP:0004808) | 1.78617933 |
| 84 | Osteomyelitis (HP:0002754) | 1.78103195 |
| 85 | Hemoptysis (HP:0002105) | 1.76173646 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 1.75946314 |
| 87 | Abnormality of eosinophils (HP:0001879) | 1.75329665 |
| 88 | Urticaria (HP:0001025) | 1.75299405 |
| 89 | Restrictive lung disease (HP:0002091) | 1.74499549 |
| 90 | Thrombocytosis (HP:0001894) | 1.74459438 |
| 91 | Stereotypic behavior (HP:0000733) | 1.72705322 |
| 92 | Fatigue (HP:0012378) | 1.70716519 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.69723400 |
| 94 | Hypertensive crisis (HP:0100735) | 1.68439835 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68202971 |
| 96 | Gingival bleeding (HP:0000225) | 1.66494974 |
| 97 | Sepsis (HP:0100806) | 1.65384627 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 1.63703032 |
| 99 | Basal cell carcinoma (HP:0002671) | 1.63292407 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.61835226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.84458584 |
| 2 | MAP4K1 | 3.35608808 |
| 3 | PRPF4B | 2.43971030 |
| 4 | TRIB3 | 2.42444947 |
| 5 | BLK | 2.23436384 |
| 6 | MAP2K3 | 2.17844711 |
| 7 | TNK2 | 2.12549915 |
| 8 | CDK12 | 2.12524083 |
| 9 | TYK2 | 2.00038362 |
| 10 | ZAP70 | 1.91744972 |
| 11 | FES | 1.90242687 |
| 12 | MARK2 | 1.87178595 |
| 13 | MAP3K13 | 1.80918492 |
| 14 | ERN1 | 1.78346536 |
| 15 | BTK | 1.70641892 |
| 16 | ICK | 1.61759888 |
| 17 | MAP3K7 | 1.61528740 |
| 18 | SIK2 | 1.60344949 |
| 19 | KSR2 | 1.58863948 |
| 20 | SYK | 1.58579118 |
| 21 | MAPK12 | 1.42271869 |
| 22 | CSK | 1.37452916 |
| 23 | PRKCH | 1.36612212 |
| 24 | NTRK3 | 1.33372510 |
| 25 | HCK | 1.30321867 |
| 26 | CDC42BPA | 1.25473353 |
| 27 | FGFR3 | 1.24970452 |
| 28 | EEF2K | 1.23384304 |
| 29 | TAOK3 | 1.21486534 |
| 30 | JAK2 | 1.21378871 |
| 31 | IRAK4 | 1.18185788 |
| 32 | JAK1 | 1.17108184 |
| 33 | JAK3 | 1.13784319 |
| 34 | FGFR4 | 1.12574003 |
| 35 | CSF1R | 1.11927059 |
| 36 | PDK1 | 1.11785193 |
| 37 | MAP3K1 | 1.11142762 |
| 38 | PIK3CG | 1.09376793 |
| 39 | MAP3K14 | 1.07191272 |
| 40 | GRK6 | 1.05685176 |
| 41 | LCK | 1.05053712 |
| 42 | SIK1 | 1.02840831 |
| 43 | SMG1 | 1.01548431 |
| 44 | ITK | 1.00237538 |
| 45 | MAP3K2 | 0.99928109 |
| 46 | KIT | 0.99698764 |
| 47 | HIPK2 | 0.99062809 |
| 48 | NTRK2 | 0.98296622 |
| 49 | MAP3K6 | 0.97664994 |
| 50 | RET | 0.94111695 |
| 51 | TXK | 0.93984537 |
| 52 | MAP3K11 | 0.92883037 |
| 53 | WNK1 | 0.91394782 |
| 54 | PDPK1 | 0.89232120 |
| 55 | TEC | 0.88095043 |
| 56 | IKBKE | 0.87916935 |
| 57 | EPHB1 | 0.85995392 |
| 58 | MARK3 | 0.85646361 |
| 59 | AKT3 | 0.83977829 |
| 60 | PKN2 | 0.83271457 |
| 61 | LYN | 0.82401123 |
| 62 | SGK3 | 0.80949576 |
| 63 | MAPK7 | 0.79658759 |
| 64 | TBK1 | 0.77564295 |
| 65 | STK38 | 0.76963719 |
| 66 | MTOR | 0.76674191 |
| 67 | STK11 | 0.74314958 |
| 68 | BRD4 | 0.73450211 |
| 69 | CDK4 | 0.72281087 |
| 70 | RAF1 | 0.71945539 |
| 71 | CAMKK1 | 0.71028546 |
| 72 | MAP3K10 | 0.71012318 |
| 73 | PRKD2 | 0.70638329 |
| 74 | SGK2 | 0.70477707 |
| 75 | MAPK11 | 0.63789888 |
| 76 | NLK | 0.61747890 |
| 77 | TYRO3 | 0.61437104 |
| 78 | RPS6KC1 | 0.60835614 |
| 79 | RPS6KL1 | 0.60835614 |
| 80 | MAP2K4 | 0.60109926 |
| 81 | PDGFRB | 0.57609372 |
| 82 | CAMK1D | 0.55321966 |
| 83 | TRPM7 | 0.54193415 |
| 84 | PIM1 | 0.53009198 |
| 85 | MELK | 0.52943258 |
| 86 | FGR | 0.51969539 |
| 87 | CAMK1G | 0.51725553 |
| 88 | RPS6KA6 | 0.51338031 |
| 89 | NTRK1 | 0.48247839 |
| 90 | MAP2K6 | 0.47861444 |
| 91 | DAPK2 | 0.47611418 |
| 92 | PRKD1 | 0.47007093 |
| 93 | SGK1 | 0.46849511 |
| 94 | FYN | 0.46782887 |
| 95 | RPS6KA2 | 0.46355594 |
| 96 | TAOK1 | 0.46223519 |
| 97 | TTN | 0.45019562 |
| 98 | MAPK4 | 0.44827693 |
| 99 | KSR1 | 0.44198267 |
| 100 | MAPK3 | 0.42220607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45452275 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.36518589 |
| 3 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.13299335 |
| 4 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.08568434 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99275497 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.94991744 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94858935 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92912513 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88738368 |
| 10 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.79084479 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70334407 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68200157 |
| 13 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.63249939 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62725353 |
| 15 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53050631 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47335237 |
| 17 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.45677773 |
| 18 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.44151810 |
| 19 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.40174102 |
| 20 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.36642049 |
| 21 | Glioma_Homo sapiens_hsa05214 | 1.36151597 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34463790 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33858638 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.31561285 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.30401387 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.29735777 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29347762 |
| 28 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.29290649 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.27026569 |
| 30 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.25303279 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22879991 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21380156 |
| 33 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18899821 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18131521 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16853801 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15421913 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.15398918 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.13329352 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09134766 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08874081 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.08653362 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07385207 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07144520 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.06344475 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05890450 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.05885352 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05809551 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00357999 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99869815 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97969611 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97537817 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97504889 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96087975 |
| 54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95047300 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.94710752 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94424701 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94108921 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93824470 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93445086 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93374916 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92941902 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92757281 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.91666188 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88825166 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87722238 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87678346 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.87276173 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86361413 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.83893325 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82281870 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.80043327 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76624658 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75911328 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74506875 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72322483 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67308729 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66934273 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.66120861 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66095929 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64910889 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.64373430 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63784884 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62741573 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62631202 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61382711 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60728498 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59913733 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59264521 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58551805 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57819829 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.57037585 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56723103 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55762438 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55472012 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52867105 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50896300 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50686184 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48994893 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.48142082 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47250895 |

